Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01727183

Ligand	Ligand name	Chain	PDB	Tanimoto
C41	ALISKIREN	C,O	2V0Z	0.7
CMD	3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)-DOXORUBICIN	A	236D	0.71
NGP	NOGALAMYCIN (PROTONATED FORM)	A	1L0R	0.71
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.7
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1E1Y	0.7
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A,B	3BLR	0.7
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1C8K	0.7
NGU	U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN	A,B	1D22	0.73
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.7
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.7
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	215D	0.72
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	235D	0.72
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A	234D	0.72
DMM	3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN	A,B	2DES	0.72
REN	(S)-reticuline	A	3FWA	0.74
REN	(S)-reticuline	A	3D2D	0.74
E3G	ESTRONE BETA-D-GLUCURONIDE	H,L	1CFV	0.72
MUS	4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID	A	1S0J	0.7
CM4	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIM	0.72
GNT	(-)-GALANTHAMINE	A	1DX6	0.75
GNT	(-)-GALANTHAMINE	A	1QTI	0.75
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.75
GNT	(-)-GALANTHAMINE	A,B	1W76	0.75
GNT	(-)-GALANTHAMINE	A	1W6R	0.75
MNG	MENOGARIL	A,B	202D	0.75
MOI	(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL	H,L	1Q0Y	0.82
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.99
NOD	N-ETHYLHYDROXY-DOXORUBICIN	A	385D	0.71
HMT	(3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine	0,1,2,3,9,A,B,C,F,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G6E	0.73
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.74
DM9	N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN	A	482D	0.75
NGM	NOGALAMYCIN	A,B,C,D	258D	0.73
NGM	NOGALAMYCIN	A	282D	0.73
NGM	NOGALAMYCIN	A,B	224D	0.73
NGM	NOGALAMYCIN	A,B	245D	0.73
NGM	NOGALAMYCIN	A,B	1QCH	0.73
NGM	NOGALAMYCIN	A	1D17	0.73
NGM	NOGALAMYCIN	A,B	1D21	0.73
NGM	NOGALAMYCIN	A,B	182D	0.73
AP1	{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID	A,B	1BL4	0.76
CM3	(2R,3R,4S)-5-FLUORO-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIN	0.7
HEH	HEDAMYCIN	A	1JHI	0.71
STG	ESTRIOL 3-(B-D-GLUCURONIDE)	H	2BFV	0.7
STG	ESTRIOL 3-(B-D-GLUCURONIDE)	H,L	1BFV	0.7